Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC26H27F4N9 |
InChIKeyJOEGMRJUEHHYFN-UHFFFAOYSA-N |
CAS Registry3073724-97-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | 14 Apr 2025 |